No connection

Search Results

LNTH vs UNH

LNTH
Lantheus Holdings, Inc.
NEUTRAL
Price
$80.59
Market Cap
$5.25B
Sector
Healthcare
AI Confidence
85%
UNH
UnitedHealth Group Incorporated
NEUTRAL
Price
$323.48
Market Cap
$293.61B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
LNTH
23.63
UNH
24.43
Forward P/E
LNTH
12.81
UNH
16.08
P/B Ratio
LNTH
4.78
UNH
3.11
P/S Ratio
LNTH
3.4
UNH
0.66
EV/EBITDA
LNTH
14.31
UNH
16.47

Profitability

Gross Margin
LNTH
61.1%
UNH
18.53%
Operating Margin
LNTH
19.07%
UNH
0.34%
Profit Margin
LNTH
15.15%
UNH
2.69%
ROE
LNTH
21.45%
UNH
12.54%
ROA
LNTH
9.28%
UNH
3.9%

Growth

Revenue Growth
LNTH
4.0%
UNH
12.3%
Earnings Growth
LNTH
--
UNH
-99.9%

Financial Health

Debt/Equity
LNTH
0.57
UNH
0.82
Current Ratio
LNTH
2.7
UNH
0.79
Quick Ratio
LNTH
2.2
UNH
0.7

Dividends

Dividend Yield
LNTH
--
UNH
2.73%
Payout Ratio
LNTH
0.0%
UNH
65.99%

AI Verdict

LNTH NEUTRAL

LNTH exhibits strong operational health with a Piotroski F-Score of 7/9 and robust liquidity (Current Ratio 2.70), though it lacks an Altman Z-Score for bankruptcy benchmarking. While the company is highly profitable with an ROE of 21.45% and a consistent track record of earnings beats, the stock trades at a significant premium to its Graham Number ($35.98) and Intrinsic Value ($23.87). The bullish outlook is supported by a low Forward P/E of 12.81 and a positive analyst target of $91.38, but the current price is disconnected from deterministic value metrics.

Strengths
Strong financial health indicated by a Piotroski F-Score of 7/9
Excellent liquidity with a Current Ratio of 2.70 and Quick Ratio of 2.20
High profitability with 21.45% ROE and 61.10% Gross Margin
Risks
Significant valuation gap between current price ($80.59) and Graham Number ($35.98)
Modest year-over-year revenue growth of only 4.00%
Bearish technical trend (0/100) despite recent 6-month recovery
UNH NEUTRAL

UnitedHealth Group presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between current price ($323.48) and defensive fair value (Graham Number: $175.91). While revenue growth remains robust at 12.3%, the company has suffered a catastrophic collapse in YoY earnings growth (-99.9%), suggesting severe short-term headwinds or one-time accounting shocks. Technical trends are currently bearish (0/100), though a recent one-month bounce and a favorable Forward P/E of 16.08 indicate analyst expectations of a recovery. The stock is currently trading at a significant premium to its intrinsic value, relying heavily on its market dominance and future earnings normalization.

Strengths
Strong consistent revenue growth (12.3% YoY)
Manageable Debt/Equity ratio of 0.82
Attractive Forward P/E (16.08) compared to current P/E (24.43)
Risks
Extreme earnings volatility (YoY Earnings Growth -99.9%)
Poor liquidity indicated by a Current Ratio of 0.79
Extremely thin operating margins (0.34%)

Compare Another Pair

LNTH vs UNH: Head-to-Head Comparison

This page compares Lantheus Holdings, Inc. (LNTH) and UnitedHealth Group Incorporated (UNH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile